241 related articles for article (PubMed ID: 26989114)
1. Atypical patterns of cardiac involvement in Fabry disease.
Coughlan JJ; Elkholy K; O'Brien J; Kiernan T
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26989114
[TBL] [Abstract][Full Text] [Related]
2. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy diagnosed after a stroke: a case report.
Umeojiako WI; Kanyal R
J Med Case Rep; 2018 Mar; 12(1):76. PubMed ID: 29562910
[TBL] [Abstract][Full Text] [Related]
4. Nomen est omen. Fabry disease.
Weidemann F; Wanner C; Breunig F
Eur J Echocardiogr; 2008 Nov; 9(6):831-2. PubMed ID: 18492655
[TBL] [Abstract][Full Text] [Related]
5. Many Faces of Fabry's Cardiomyopathy.
Jain R; Kalvin L; Johnson B; Muthukumar L; Khandheria BK; Tajik AJ
JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
[No Abstract] [Full Text] [Related]
6. Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?
Labombarda F; Saloux E; Milesi G; Bienvenu B
Echocardiography; 2017 Apr; 34(4):504-510. PubMed ID: 28256008
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
[TBL] [Abstract][Full Text] [Related]
8. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.
Koskenvuo JW; Engblom E; Kantola IM; Hartiala JJ; Saraste A; Kiviniemi TO; Mononen I; Saraste M
Clin Physiol Funct Imaging; 2009 May; 29(3):177-80. PubMed ID: 19320660
[TBL] [Abstract][Full Text] [Related]
9. Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease.
Cianciulli TF; Saccheri MC; Fernández SP; Fernández CC; Rozenfeld PA; Kisinovsky I
Echocardiography; 2015 May; 32(5):860-3. PubMed ID: 25684266
[TBL] [Abstract][Full Text] [Related]
10. Fabry disease in cardiology practice: Literature review and expert point of view.
Hagège A; Réant P; Habib G; Damy T; Barone-Rochette G; Soulat G; Donal E; Germain DP
Arch Cardiovasc Dis; 2019 Apr; 112(4):278-287. PubMed ID: 30826269
[TBL] [Abstract][Full Text] [Related]
11. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.
Chimenti C; Pieroni M; Morgante E; Antuzzi D; Russo A; Russo MA; Maseri A; Frustaci A
Circulation; 2004 Aug; 110(9):1047-53. PubMed ID: 15313943
[TBL] [Abstract][Full Text] [Related]
13. Detection of Urinary Mulberry Bodies Leads to Diagnosis of Fabry Cardiomyopathy: A Simple Clue in the Urine Sediment.
Yano T; Takahashi R; Yamashita T; Nagano N; Ishikawa A; Sakurai A; Maruyama H; Miura T
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203563
[No Abstract] [Full Text] [Related]
14. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
[TBL] [Abstract][Full Text] [Related]
15. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy with late enhancement of the non-hypertrophied left ventricular segments.
Efthimiadis GK; Spanos GP; Giannakoulas G; Boufidou A; Parcharidou DG; Karvounis H; Styliadis I; Parcharidis GE
Hellenic J Cardiol; 2008; 49(2):114-6. PubMed ID: 18459471
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular apical hypertrophy in a transplanted heart: a case report.
Ibe U; Balakumaran K; Arora S
BMC Cardiovasc Disord; 2019 Apr; 19(1):81. PubMed ID: 30943916
[TBL] [Abstract][Full Text] [Related]
18. Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease.
Hanneman K; Karur GR; Wasim S; Wald RM; Iwanochko RM; Morel CF
Radiology; 2020 Jan; 294(1):42-49. PubMed ID: 31660802
[TBL] [Abstract][Full Text] [Related]
19. Electrocardiographic signs of hypertrophy in fabry disease-associated hypertrophic cardiomyopathy.
Kampmann C; Wiethoff CM; Martin C; Wenzel A; Kampmann R; Whybra C; Miebach E; Beck M
Acta Paediatr Suppl; 2002; 91(439):21-7. PubMed ID: 12572838
[TBL] [Abstract][Full Text] [Related]
20. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
